This is not the most recent version of the article. View current version (9 OCT 2014)

Intervention Review

Inhaled corticosteroids for cystic fibrosis

  1. Ian M Balfour-Lynn1,*,
  2. Karen Welch2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 24 SEP 2012

DOI: 10.1002/14651858.CD001915.pub3

How to Cite

Balfour-Lynn IM, Welch K. Inhaled corticosteroids for cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD001915. DOI: 10.1002/14651858.CD001915.pub3.

Author Information

  1. 1

    Royal Brompton Hospital, Dept. Paediatric Respiratory Medicine, London, UK

  2. 2

    University of Edinburgh, Public Health Sciences, Edinburgh, UK

*Ian M Balfour-Lynn, Dept. Paediatric Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 14 NOV 2012


This is not the most recent version of the article. View current version (09 OCT 2014)

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.